Stock Comparison

TWST vs UNH

Twist Bioscience Corp vs UnitedHealth Group Inc

The Verdict

TWST takes this one.

Winner

TWST

Twist Bioscience Corp

7.0

out of 10

Solid Pick

UNH

UnitedHealth Group Inc

0.3

out of 10

Distressed

Head-to-Head

$4.2B

Market Cap

$365.5B

14.7

P/E Ratio

30.3

-19.9%

Profit Margin

2.7%

-17.5%

Return on Equity

12.4%

0.5

Debt-to-Equity

0.8

Aggressive

Overall Risk

Moderate

7.0

DVR Score

0.3

The Deep Dive

TWST7.0/10

Twist Bioscience maintains its high-risk, high-reward profile with compelling 10x growth potential, driven by its unique silicon-based DNA synthesis platform and strategic entry into DNA data storage. Q2 FY26 results confirmed strong revenue growth and expanded clonal gene offerings, reinforcing its market opportunity and technological moat. However, the reported EPS miss for Q2 FY26 and ongoing i...

Full TWST Analysis

UNH0.3/10

UnitedHealth Group (UNH) remains a robust, high-quality mega-cap in the mature and highly regulated healthcare sector. Q1 2026 adjusted EPS of $7.23, a recent dividend increase to $2.32, and some analyst upgrades (e.g., Truist to $440, Goldman Sachs Conviction Buy) reflect solid operational performance and financial strength. However, these are characteristics of a stable compounder, not a company...

Full UNH Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.